Antimigraine research hub

RANDOMISED, CROSSOVER, SIMPLE-BLINDED, BIOEQUIVALENCE CLINICAL TRIAL OF ALMOTRIPTAN 12.5 MG ORODISPERSIBLE TABLETS VERSUS ALMOTRIPTAN 12.5 MG FILM-COATED TABLETS, AFTER A SINGLE ORAL DOSE ADMINISTRATION TO HEALTHY VOLUNTEERS UNDER FASTING

This study is comparing two types of almotriptan tablets, a medicine for migraines, to see if they work the same way in the body. We're testing if a new fast-dissolving tablet is as good as the standard one in healthy adults who haven't eaten for a while.